共 50 条
Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults
被引:14
|作者:
Reid, Michael
[1
]
Ma, Yifei
[1
]
Scherzer, Rebecca
[1
,2
]
Price, Jennifer C.
[1
]
French, Audrey L.
[3
,4
]
Plankey, Michael W.
[5
]
Grunfeld, Carl
[1
,2
]
Tien, Phyllis C.
[1
,2
]
机构:
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Dept Veteran Affairs Med Ctr, Med Serv, San Francisco, CA USA
[3] Stroger Hosp, Dept Med, Chicago, IL USA
[4] Rush Univ, Chicago, IL 60612 USA
[5] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA
来源:
关键词:
hepatitis C virus;
HIV;
inflammation;
insulin resistance;
microbial translocation;
monocyte activation;
WOMENS INTERAGENCY HIV;
ANTIRETROVIRAL THERAPY EXPOSURE;
HOMEOSTASIS MODEL ASSESSMENT;
TYPE-2;
DIABETES-MELLITUS;
GLUCOSE CLAMP TECHNIQUE;
SOLUBLE CD163;
MICROBIAL TRANSLOCATION;
IMMUNE ACTIVATION;
RISK;
OBESITY;
D O I:
10.1097/QAD.0000000000001345
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Objectives: HIV/hepatitis C virus (HCV) coinfection is associated with insulin resistance, but the mechanism is unclear. We hypothesized that intestinal epithelial damage and the consequent monocyte/macrophage activation and inflammation explain this perturbation. Design: Cross-sectional study of 519 adults (220 HIV+/HCV-; 64 HIV-/HCV+; 89 HIV+/HCV+; 146 HIV-/HCV-). Methods: We used multivariable linear regression to evaluate associations of HIV and HCV with the homeostasis model assessment of insulin resistance (HOMA-IR) and if intestinal fatty (FA) acid binding protein (I-FABP, a marker of gut epithelial integrity), soluble CD14 (sCD14) and soluble CD163 (sCD163) (markers of monocyte/macrophage activation), and IL-6 (an inflammatory cytokine) mediated this association. Results: HIV+/HCV+ and HIV-/HCV+ had greater demographic-adjusted HOMA-IR [mean (95% confidence interval (CI)): 1.96 (1.51, 2.54) and 1.65 (1.22, 2.24)] than HIV+/HCV- and HIV-/HCV- [1.41 (1.18, 1.67) and 1.44 (1.17, 1.75), respectively]. After additional adjustment for lifestyle and metabolic factors, HIV+/HCV+ remained associated with 36% (95% CI: 4, 80%) greater HOMA-IR relative to HIV+/HCV+, whereas HIV-/HCV+ and HIV+/HCV- had smaller differences. Adjustment for sCD163 substantially attenuated the difference between HIV+/HCV+ and HIV-/HCV+; adjustment for I-FABP, sCD14, and IL-6 had little effect. Higher sCD163 was independently associated with 19% (95% CI: 7, 33%), 26% (95% CI: 15, 39%), 25% (95% CI: 14, 37%), and 23% (95% CI: 11, 36%) greater HOMA-IR in HIV+/HCV+, HIV-/HCV+, HIV+/HCV-, and HIV-/HCV- (all estimates per doubling of sCD163). I-FABP, sCD14, and IL-6 were not associated with HOMA-IR. Conclusion: HIV/HCV coinfection is associated with greater HOMA-IR, even after controlling for demographic, lifestyle, and metabolic factors. sCD163, which appears independent of intestinal epithelial damage and inflammation, partly explains this association. Our findings that the association of sCD163 with HOMA-IR occurred even in the absence of HIV and HCV, indicate that viral and nonviral factors affect sCD163 levels. Its role in insulin resistance needs elucidation. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:385 / 393
页数:9
相关论文